Skip to main content
Premium Trial:

Request an Annual Quote

First the Nobel, Next the NYT Interview

Carol Greider, Johns Hopkins researcher and a winner of the Nobel prize last week for her work on telomeres, submits to a Q&A with the New York Times. Asked about the timing of this prize -- Greider has for years been shortlisted as a potential laureate -- she responded, "I think it’s clear now that the basic science we did is important to understanding cancers, some human genetic diseases and the age associated degenerative diseases. The clinical relevance still needs to be understood in the medical community."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.